Provided by Tiger Fintech (Singapore) Pte. Ltd.

Leap Therapeutics Inc

0.2656
-0.0488-15.52%
Post-market: 0.28450.0189+7.12%19:48 EDT
Volume:911.67K
Turnover:247.36K
Market Cap:10.96M
PE:-0.15
High:0.3071
Open:0.3050
Low:0.2223
Close:0.3144
Loading ...

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Benzinga
·
27 Mar

Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial

MT Newswires Live
·
26 Mar

BRIEF-Leap Therapeutics Reports Fourth Quarter And FY 2024 Results

Reuters
·
26 Mar

Leap Therapeutics Q4 Operating Expenses USD 16.125 Million

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
26 Mar

Leap Therapeutics Reports Positive Updated Data From Sirexatamab Colorectal Cancer Study

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

PR Newswire
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
14 Mar

Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright

MT Newswires Live
·
30 Jan

Baird Downgrades Leap Therapeutics to Neutral From Outperform, Cuts Price Target to $1.25 From $9

MT Newswires Live
·
29 Jan

HC Wainwright Downgrades Leap Therapeutics to Neutral From Buy

MT Newswires Live
·
29 Jan

Leap Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
29 Jan

Leap Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
29 Jan

U.S. RESEARCH ROUNDUP-Apple, Coinbase Global, Nextracker

Reuters
·
29 Jan

Leap Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.25 From $9

THOMSON REUTERS
·
29 Jan

Gold Gains 1%; Boeing Shares Rise Following Q4 Results

Benzinga
·
29 Jan

Leap Therapeutics Shares Down 62.8% After Discontinuing Late-Stage Trials of Gastric Cancer Treatment

THOMSON REUTERS
·
28 Jan